Abstract
<h3>To the Editor.—</h3> The drugs effective in post-kala-azar dermal leishmaniasis (PKDL) include parenteral administration of sodium antimony gluconate, amphotericin B, or pentamidine, of which sodium antimony gluconate is the treatment of choice.<sup>1</sup>The problem of giving a dose as high as 8.5 to 10 mL daily for the recommended period of 4 months is not only that the patient needs supervision but that it is difficult for the patient to endure. In an effort to find a suitable orally administered drug, we decided to assess the efficacy of ketoconazole (Nizoral tablets [200mgl, Janssen Pharmaceutica, Bombay, India) in PKDL, as this drug has recently proved useful in visceral leishmaniasis.<sup>2</sup> <h3>Subjects, Methods, and Results.—</h3> Four male patients with PKDL between 20 and 25 years of age were admitted into the study after obtaining their consent. The duration of the skin lesions varied from 2 to 4 years. Cutaneous examination
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
